Showing results (61-70 of 274) with videos related to
Sort By:
Pageof 28
Cancer Science|January 22, 2009
Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivoNick Devoogdt, Nabila Rasool, Ebony Hoskins, et al.Leukemia & Lymphoma|July 16, 2005
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology GroupDouglas P Olson, Barbara J Taylor, Mei La, et al.Cancer Letters|February 2, 2024
Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patientsMorgan A Butrovich, Jiyue Qin, Xiaonan Xue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Design issues of randomized phase II trials and a proposal for phase II screening trialsLawrence V Rubinstein, Edward L Korn, Boris Freidlin, et al.Plos One|April 9, 2009
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasomeVictoria M Virador, Ben Davidson, Josephine Czechowicz, et al.Gynecologic Oncology|October 5, 2016
The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignanciesGrace Mishkin, Lori M Minasian, Elise C Kohn, et al.The Journal of Biological Chemistry|May 17, 2003
CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteinsHoward Doong, Kathryn Rizzo, Shengyun Fang, et al.International Journal of Cancer|May 9, 2008
Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiencyJia-Lin Yang, Xian-Jun Qu, Yan Yu, et al.The Lancet. Oncology|September 15, 2014
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 studyJoyce F Liu, William T Barry, Michael Birrer, et al.Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.Pageof 28